Protective effect of tanshinone II A on signal transduction system protein kinase B in rats with myocardial hypertrophy
Tóm tắt
The effects of tanshinone II A on cell signal transduction system protein kinase B in rats with myocardial hypertrophy induced by the abdominal aorta partial coarctation were investigated. Rat models of myocardial hypertrophy were established by using abdominal aorta partial coarctation method. Forty-eight rats were randomly divided into sham group (S group), model group (M group), valsartan treatment group (X group), low-dose tanshinone treatment group (LD group), medium-dose tanshinone treatment group (MD group), and high-dose tanshinone treatment group (HD group) (n = 8 in each group). Left ventricular mass index (LVMI), left ventricular posterior wall (LVPW), and septal thickness (IVS) were detected by high frequency ultrasonography. Myocardial fiber diameter (MFD) was examined by Hematoxylin-Eosin (HE) staining, and the contents of phosphorylated protein kinase B (p-Akt) and p-Gsk3β in myocardium were assayed by Western blot. The results showed that compared with S group, the values of LVMI, LVPW, IVS and MFD were increased in other groups (P<0.05), and the contents of p-Akt, and p-Gsk3β were also increased in other groups. As compared with MD group, the values of LVMI, LVPW, IVS and MFD were decreased in all treatment groups (P<0.05), and the contents of p-Akt, and p-Gsk3β were also decreased in all treatment groups. However, there were no significant differences among LD, MD, and HD groups (P>0.05), and there were no significant differences between X group and tanshinone treatment groups (P>0.05). It was suggested that tanshinone II A could prevent myocardial hypertrophy by its action on the Akt signaling pathway.
Tài liệu tham khảo
Kang Y J. Cardiac hypertrophy: a risk factor for QT2prolon2 gation and cardiac sudden death. Toxicol Pathol, 2006, 34(10): 58–66
Sun L P, Zheng Z. The effects of sodium tanshinone II A sulfonate on activation of NF-κB on hypertrophic myocardial cells. Shiyong Laonian Yixue, 2004, 18(1): 25–27 (in Chinese)
Xu S Y, Bian R L, Chen X. Pharmacological experiments methodology. Beijing: People’ Health Press, 2002, 1026–1028
Frey N, Olson E N. Cardiac hypertrophy: the good, the bad, and the ugly. Ann Rev Physiol, 2003, 65: 45–79
James M A, Saadeh A M, Jones J V. Wall stress and hypertension. J Cardiovasc Risk, 2000, 30(7): 187–190
Spirito P, Autore C. Management of hypertrophic cardiomyopathy. BMJ, 2006, 322(7552): 1251–1255
Hu J, Zhang C T, Pu J, Quan X Q, Lv J G, Bai R, Wei Y, Zeng X L. Effects of Perindopril on Ventricular Arrhythmias in Rabbits with Cardiac Hypertrophy. Hua Zhong Ke Ji Da Xue Xue Bao (Yi Xue Ban), 2008, 37(5): 688–690 (in Chinese)
Ke J, Zhang C T, Ma Y X, Liu J, Liu N, Ruan Y F, Lin L. The Roles of Calmodulin Kinase II Inhibitor in Ventricular Arrhythmias in Rabbits with Cardiac Hypertrophy. Hua Zhong Ke Ji Da Xue Xue Bao (Yi Xue Ban), 2007, 36(2): 183–190 (in Chinese)
Li L F, Chen L W. The mechanisms of myocardial hypertrophy. Hai Nan Yi Xue, 2008, 19(7): 123–125 (in Chinese)
Wang Y. Signal transduction in cardiac hypertrophy-dissecting compensatory versus pathological pathways utilizing a transgenic approach. Curr Opin Pharmacol, 2001, 41(1): 134–140
Morisco C, Zebroski D, Condorelli G. The Akt-glycogen synthase kinase 3β pathway regulates transcription atrial natriiuretic factor induced by β-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem, 2000, 275(19): 14466–14475
Matsui T, Nagoshi T, Rosenzweig A. Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle, 2003, 2(3): 220–223
Cao W, Shi F X, Phosphodiesterase type 3B: Downstream Factor of PI3k/PKB pathway as well as its clinical research, Xi Bao ShengWu Xue Za Zhi, 2007, 29(6): 800–804 (in Chinese)
Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J, 2001, 359(1): 1–16
Antos C L, McKinsey T A, Frey N, Kutschke W, McAnally J, Shelton J M, Richardson J A, Hill J A, Olson E N. Activated glycogen synthase-3β suppresses cardial hypertrophy in vivo. Proc Natl Acad Sci USA, 2002, 99(2): 907–912
Shio Jima I, Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev, 2006, 20(24): 3347–3365
Heineke J, Molkentin J D. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat Rev Mol Cell Biol, 2006, 7(8): 589–600
Balakumar P, Singh M. The possible role of caspase-3 in pathological and physiological cardiac hypertrophy in rats. Basic Clin Pharmacol Toxicol, 2006, 99(6): 418–424
Gao N, Flynn D C, Zhang Z. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/ p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol, 2004, 287(2): C281–C291
Matsui T, Li L, Wu J C, Cook S A, Naqoshi T, Picard M H, Liao R, Rosenzweiq A. Phenotypix spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem, 2002, 277(25): 22896–22901
Shioi T, Mcmullen J R, Kang P M, Douqlas P S, Obata T, Franke T F, Cantley L C, Izumo S. Akt/Protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol, 2002, 22(8): 2799–2809
McMullen J R, Izumo S. Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy. Novartis Found Symp, 2006, 274: 90–111
Zhou Y, Zhang J P, Wu M H, Liu H, Zhao Z G, He S Y, Wang Y T, Chu L. Influence of “YiQi Qiang Xin Decoction” on pressure overload myocardial hypertrophy. Shang Hai Zhong Yi Yao Za Zhi, 2008, 42(5): 80–82 (in Chinese)
Sun L P, Zheng Z. The Effect of Salvia Miltiorrhiza Bge on left ventricular hypertrophy and the expression of tumor necrosis factor-α in spontaneously hypertensive rats. Gao Xue Ya Za Zhi, 2004, 12(3): 238–241 (in Chinese)
Gong L Y, Zheng Z, Xiong W, Sun L P. Tanshinone II A prevents angiotensin II-induced hypertrophy of cardiomyocytes from rat. Hua Xi Yao Xue Za Zhi, 2004, 9(1): 24–27 (in Chinese)
Jiang F L, Feng J, Zheng Z. Effect of sodium tanshinone II-A sulfonate on activation of extracellular signal-regulated kinase 1/2 in angiotensin II-induced cardiomyocyte hypertrophy. Zhong Guo Yao Li Xue Tong Bao, 2008, 24(3): 307–312 (in Chinese)
Li Y S, Wang Z H, Wang J, Yan L, Yong Y Q, Liang Q S, Zheng Z, Yang G T. Effect of tashinone II A on the nitric oxide synthase gene expression and intracellular Ca∼(2 +) level in the hypertrophic cadiocytes of pressure-overloaded rats. Hua Zhong Ke Ji Da Xue Xue Bao (Yi Xue Ban), 2008, 37(3): 286–289 (in Chinese)
Yang T, Zhang W, Zhang L. Inhibitory effects of L-arginine-nitric oxide pathway on formation of pathological cardiac hypertrophy and the related mechanisms. Di Er Jun Yi Da Xue Xue Bao, 2008, 29(2): 177–183 (in Chinese)
Ouyang X, Takahashi K, Komatsu K, Nakamura N, Hattori M, Baba A, Azuma J. Protective effect of salvia miltiorrhiza on angiotensin II induced hypertrophic responses in neonatal rat cardial cells. Jpn J pharmacol, 2001, 87(4): 289–296
Pan G J, Wang X L. Effect of Radix Salviae Miltiorrhizae (RAM) on myocardiac hypertrophy in rat model of over-loading pressure. Zhong Guo Fen Zi Xin Zhang Bing Xue Za Zhi, 2007, 7(1): 34–36 (in Chinese)